These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35893550)

  • 1.
    Refrégier G; Genestet C
    Microorganisms; 2022 Jul; 10(8):. PubMed ID: 35893550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?
    Moliva JI; Turner J; Torrelles JB
    Vaccine; 2015 Sep; 33(39):5035-41. PubMed ID: 26319069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EVOLUTION OF MYCOBACTERIUM TUBERCULOSIS AND IMPLICATIONS FOR VACCINE DEVELOPMENT.
    Gagneux S
    Ethiop Med J; 2016 Apr; 54(2):95-100. PubMed ID: 27476231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine strategies against cystic fibrosis pathogens.
    Le Moigne V; Gaillard JL; Herrmann JL
    Hum Vaccin Immunother; 2016 Mar; 12(3):751-6. PubMed ID: 26618824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Anti-tuberculosis Battle in Greece in the 1800s and 1900s.
    Michaleas SN; Protogerou AD; Sipsas NV; Panayiotakopoulos G; Angelakis AC; Michailidou C; Karamanou M
    Cureus; 2022 Jun; 14(6):e26023. PubMed ID: 35865416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and novel approaches to vaccine development against tuberculosis.
    Cayabyab MJ; Macovei L; Campos-Neto A
    Front Cell Infect Microbiol; 2012; 2():154. PubMed ID: 23230563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-mediated immunity against tuberculosis: implications for vaccine development.
    Achkar JM; Casadevall A
    Cell Host Microbe; 2013 Mar; 13(3):250-62. PubMed ID: 23498951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targets and strategies for vaccine development against SARS-CoV-2.
    Malik JA; Mulla AH; Farooqi T; Pottoo FH; Anwar S; Rengasamy KRR
    Biomed Pharmacother; 2021 May; 137():111254. PubMed ID: 33550049
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Jia Q; Masleša-Galić S; Nava S; Horwitz MA
    mBio; 2022 Jun; 13(3):e0068722. PubMed ID: 35642945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Good hygiene is still our best weapon against the spread of staph infection.
    PAINE TF
    Mod Hosp; 1960 Feb; 94():100-6. PubMed ID: 14429831
    [No Abstract]   [Full Text] [Related]  

  • 12. Developing vaccines to prevent sustained infection with Mycobacterium tuberculosis: Conference proceedings: National Institute of Allergy and Infectious Diseases, Rockville, Maryland USA, November 7, 2014.
    Vaccine Prevention of Sustained Mycobacterium tuberculosis Infection Summary Group
    Vaccine; 2015 Jun; 33(26):3056-64. PubMed ID: 25869889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. After 100 Years of BCG Immunization against Tuberculosis, What Is New and Still Outstanding for This Vaccine?
    Flores-Valdez MA
    Vaccines (Basel); 2021 Dec; 10(1):. PubMed ID: 35062718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
    Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
    Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strong homology between SARS-CoV-2 envelope protein and a Mycobacterium sp. antigen allows rapid diagnosis of Mycobacterial infections and may provide specific anti-SARS-CoV-2 immunity via the BCG vaccine.
    Nuovo G; Tili E; Suster D; Matys E; Hupp L; Magro C
    Ann Diagn Pathol; 2020 Oct; 48():151600. PubMed ID: 32805515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and protective efficacy of "Mycobacterium w" against Mycobacterium tuberculosis in mice immunized with live versus heat-killed M. w by the aerosol or parenteral route.
    Gupta A; Geetha N; Mani J; Upadhyay P; Katoch VM; Natrajan M; Gupta UD; Bhaskar S
    Infect Immun; 2009 Jan; 77(1):223-31. PubMed ID: 18981249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How far have we reached in tuberculosis vaccine development?
    Kumar H; Malhotra D; Goswami S; Bamezai RN
    Crit Rev Microbiol; 2003; 29(4):297-312. PubMed ID: 14636041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can the battle against tuberculosis gain from epigenetic research?
    Esterhuyse MM; Linhart HG; Kaufmann SH
    Trends Microbiol; 2012 May; 20(5):220-6. PubMed ID: 22464289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-benefit analysis of vaccination against Mycobacterium avium ssp. paratuberculosis in dairy cattle, given its cross-reactivity with tuberculosis tests.
    Groenendaal H; Zagmutt FJ; Patton EA; Wells SJ
    J Dairy Sci; 2015 Sep; 98(9):6070-84. PubMed ID: 26117348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.